In the world of women’s health, few areas have been as overlooked and underserved as pelvic health. For decades, patients suffering from chronic pelvic pain and related conditions have faced outdated treatments, limited options, and a lack of understanding from the medical community. Enter Hyivy Health, a Canadian startup that’s not just disrupting the status quo – it’s completely redefining how we…
Helaina, a biotechnology company focused on human equivalent bioactive proteins, has announced a $45 million Series B funding round bringing the company’s total equity funding to $83 million. Avidity Partners led the round, with participation from Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity, and Primary Venture Partners, among others. The funding…
Joylux and Respin, the midlife wellness brand founded by actress Halle Berry, have announced a partnership aimed at addressing intimate health issues faced by peri/post-menopausal women. This collaboration introduces two new products: an intimacy gel named LET’S SPIN and a special edition of the vFit Plus device. The partnership responds to the needs of the estimated 60 million women in the U.S.…
Menopause company Bonafide Health has announced the launch of Thermella, a new hormone-free, prescription-free neurokinin 3 receptor (NK3R) antagonist designed to relieve hot flashes and night sweats. The botanical supplement targets the thermoregulatory zone and is clinically tested to reduce vasomotor symptoms (VMS). Thermella operates by rebalancing the body’s thermoregulatory center through blocking the neurokinin B (NKB) pathway, which is the same…
Ovia Health by Labcorp has announced the launch of its new Postpartum Experience, a personalized and comprehensive 12-month program designed to assist women in managing the postpartum period. The Postpartum Experience aims to address various aspects of recovery through personalized recovery modes, symptom tracking and alerts, as well as mental health support. It will be accessible to members of Ovia Health Plans…
Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Luminate raises $15M to revolutionize cancer care with hair-saving chemo helmet and home treatment solutions. Cercle secures $6M in seed funding to expand AI-driven women’s healthcare…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
In a significant move that’s turning heads in the fertility benefits industry, e-commerce giant Amazon has reportedly chosen Maven Clinic to replace Progyny as its primary fertility benefits provider. This development, highlighted in a recent J.P. Morgan analyst report, marks a notable moment in the competitive landscape of digital health and family care services. Anu Duggal, an investor in Maven through Female…
